Search
Now showing items 31-40 of 56
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
(Sage, 2020-06-11)
[Abstract]
Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ...
Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy: data from the nordictus registry
(Frontiers, 2020-11-26)
[Abstract] Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to ...
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: consensus document and practice guidance
(Elsevier, 2021-12-11)
[Abstract]
Introduction: Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the ...
Liquid chromatography fingerprint analysis of released compounds in plasmas samples of stroke patients after thrombolytic treatment
(MDPI, 2023-01-05)
[Abstract] Plasma samples obtained from stroke patients treated with recombinant tissue-type plasminogen activator (rt-PA) and not treated with rt-PA were evaluated with different HPLC methodologies to obtain information ...
Depression in major neurodegenerative diseases and strokes: a critical review of similarities and differences among neurological disorders
(MDPI, 2023-02-13)
[Abstract] Depression and anxiety are highly prevalent in most neurological disorders and can have a major impact on the patient’s disability and quality of life. However, mostly due to the heterogeneity of symptoms and ...
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
(Elsevier, 2023-12-15)
[Abstract]
Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ...
Síndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: epidemiología y presentación clínica de la serie española
(Elsevier, 2022-05-23)
[Resumen] Introducción. Se describen las características epidemiológicas y clínicas de los casos de síndrome de trombosis con trombocitopenia (STT) notificados en España.
Métodos. Se incluyeron los casos de trombosis ...
A randomized trial on hemodynamic optimization of cerebral perfusion after successful endovascular therapy in patients with acute ischemic stroke (HOPE)
(Karger, 2024-08-29)
[Abstract] Introduction: In patients with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion, optimal blood pressure (BP) management following endovascular treatment (EVT) has not yet been ...
Stroke prevention in patients with arterial hypertension: recommendations of the Spanish Society of Neurology's Stroke Study Group
(Elsevier, 2021-04-23)
[Abstract]
Objective: To update the recommendations of the Spanish Society of Neurology on primary and secondary stroke prevention in patients with arterial hypertension.
Development: We proposed several questions ...
Characteristics of stroke units and stroke teams in Spain in 2018: Pre2Ictus project
(Elsevier, 2022-06-30)
[Abstract]
Introduction: The aim of this work is to describe the characteristics of stroke units and stroke teams in Spain.
Method: We performed a cross-sectional study based on an ad hoc questionnaire designed by ...
